Timothy J Petersen

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trial
    Timothy Petersen
    Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA
    Psychopharmacol Bull 41:34-45. 2008
  2. ncbi request reprint NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients
    Timothy Petersen
    Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, 15 Parkman Street, WAC 812, MA, Boston 02114, USA
    Psychiatry Res 109:9-16. 2002
  3. ncbi request reprint Clinical characteristics of depressed patients with comorbid diabetes mellitus
    Timothy Petersen
    Depression Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Int Clin Psychopharmacol 21:43-7. 2006
  4. ncbi request reprint Reach of benchmark psychiatric trial results to community-based providers: a case study of CATIE
    Timothy J Petersen
    Massachusetts General Hospital Department of Psychiatry, Division of Postgraduate Education, Boston, MA 02114, USA
    J Clin Psychiatry 69:1081-6. 2008
  5. ncbi request reprint Empirical testing of two models for staging antidepressant treatment resistance
    Timothy Petersen
    Depression Clinical and Research Program, Massachusetts General Hospital, 15 Parkman Street, WACC 812, Boston, MA 02114, USA
    J Clin Psychopharmacol 25:336-41. 2005
  6. doi request reprint Do comorbid anxiety disorders impact treatment planning for outpatients with major depressive disorder?
    Timothy Petersen
    Massachusetts General Hospital, Department of Psychiatry, Division of Postgraduate Education, 1 Bowdoin Square, 7th Floor, Boston, MA 02114, USA
    Psychiatry Res 169:7-11. 2009
  7. ncbi request reprint Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine
    T Petersen
    Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA, USA
    Psychol Med 34:555-61. 2004
  8. ncbi request reprint Psychosocial functioning in patients with treatment resistant depression
    Timothy Petersen
    Department of Psychiatry, Depression Clinical and Research Program, Massachusetts General Hospital, 15 Parkman Street, WAC 812 Boston, MA 02114, USA
    Eur Psychiatry 19:196-201. 2004
  9. ncbi request reprint Enhancing the efficacy of antidepressants with psychotherapy
    Timothy J Petersen
    Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA 02114, USA
    J Psychopharmacol 20:19-28. 2006
  10. ncbi request reprint A survey of prescribing practices in the treatment of depression
    Timothy Petersen
    Depression Clinical and Research Program, Massachusetts General Hospital, Boston 02114, USA
    Prog Neuropsychopharmacol Biol Psychiatry 26:177-87. 2002

Detail Information

Publications26

  1. ncbi request reprint Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trial
    Timothy Petersen
    Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA
    Psychopharmacol Bull 41:34-45. 2008
    ..To describe and examine, in a sample of depressed outpatients, the relationship between level of response to a previous SSRI or SNRI antidepressant trial and subsequent response to duloxetine hydrochloride...
  2. ncbi request reprint NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients
    Timothy Petersen
    Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, 15 Parkman Street, WAC 812, MA, Boston 02114, USA
    Psychiatry Res 109:9-16. 2002
    ....
  3. ncbi request reprint Clinical characteristics of depressed patients with comorbid diabetes mellitus
    Timothy Petersen
    Depression Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Int Clin Psychopharmacol 21:43-7. 2006
    ..These findings suggest that depressed diabetic patients are more similar than not to non-diabetic depressed patients, although important differences exist...
  4. ncbi request reprint Reach of benchmark psychiatric trial results to community-based providers: a case study of CATIE
    Timothy J Petersen
    Massachusetts General Hospital Department of Psychiatry, Division of Postgraduate Education, Boston, MA 02114, USA
    J Clin Psychiatry 69:1081-6. 2008
    ....
  5. ncbi request reprint Empirical testing of two models for staging antidepressant treatment resistance
    Timothy Petersen
    Depression Clinical and Research Program, Massachusetts General Hospital, 15 Parkman Street, WACC 812, Boston, MA 02114, USA
    J Clin Psychopharmacol 25:336-41. 2005
    ..This study was undertaken to empirically test 2 recent models for staging treatment resistance...
  6. doi request reprint Do comorbid anxiety disorders impact treatment planning for outpatients with major depressive disorder?
    Timothy Petersen
    Massachusetts General Hospital, Department of Psychiatry, Division of Postgraduate Education, 1 Bowdoin Square, 7th Floor, Boston, MA 02114, USA
    Psychiatry Res 169:7-11. 2009
    ..Our results indicate that practitioners are making unique recommendations based on comorbid anxiety diagnoses, but outcome studies are now needed to determine the most effective treatment methods for this patient population...
  7. ncbi request reprint Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine
    T Petersen
    Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA, USA
    Psychol Med 34:555-61. 2004
    ..The goal of this study was to examine whether CBT would help maintain attributional style changes experienced by patients during acute phase fluoxetine treatment...
  8. ncbi request reprint Psychosocial functioning in patients with treatment resistant depression
    Timothy Petersen
    Department of Psychiatry, Depression Clinical and Research Program, Massachusetts General Hospital, 15 Parkman Street, WAC 812 Boston, MA 02114, USA
    Eur Psychiatry 19:196-201. 2004
    ..This is particularly true for those with treatment resistant depression (TRD). However, to date, no systematic assessments of psychosocial functioning for patients with TRD have been conducted...
  9. ncbi request reprint Enhancing the efficacy of antidepressants with psychotherapy
    Timothy J Petersen
    Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA 02114, USA
    J Psychopharmacol 20:19-28. 2006
    ....
  10. ncbi request reprint A survey of prescribing practices in the treatment of depression
    Timothy Petersen
    Depression Clinical and Research Program, Massachusetts General Hospital, Boston 02114, USA
    Prog Neuropsychopharmacol Biol Psychiatry 26:177-87. 2002
    ..The purpose of this study was to examine prescribing practices in a sample of psychiatrists attending a psychopharmacology review course and compare these results with empirical evidence...
  11. ncbi request reprint Early-onset depression and the emotional and behavioral characteristics of offspring
    Timothy J Petersen
    Depression Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Depress Anxiety 18:104-8. 2003
    ..This finding may be significant in uncovering sources of vulnerability and formulating intervention strategies for offspring of depressed parents...
  12. ncbi request reprint Treatment-resistant depression and Axis II comorbidity
    Timothy Petersen
    Depression Clinical and Research Program, Massachusetts General Hospital, Boston, Mass 02114, USA
    Psychother Psychosom 71:269-74. 2002
    ....
  13. ncbi request reprint Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder
    George I Papakostas
    Department of Psychiatry, Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA 02114, USA
    J Clin Psychiatry 66:1326-30. 2005
    ..The purpose of this study was to test this hypothesis in depressed outpatients who have not experienced significant clinical improvement following an adequate trial of a selective serotonin reuptake inhibitor (SSRI)...
  14. ncbi request reprint Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder
    George I Papakostas
    Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, 15 Parkman Street, WAC 812, Boston, MA 02114, USA
    J Clin Psychiatry 65:217-21. 2004
    ..The purpose of this study is to test this hypothesis in depressed outpatients who have not experienced significant clinical improvement following an adequate trial of a selective serotonin reuptake inhibitor (SSRI)...
  15. ncbi request reprint Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder
    George I Papakostas
    Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, 15 Parkman Street, WACC 812, Boston, MA 02214, USA
    J Clin Psychiatry 65:543-6. 2004
    ..In the present study we assessed the relationship between somatic symptoms and the time to onset of clinical response to fluoxetine in patients with major depressive disorder (MDD)...
  16. ncbi request reprint A description of next-step switching versus augmentation practices for outpatients with treatment-resistant major depressive disorder enrolled in an academic specialty clinic
    George I Papakostas
    Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Ann Clin Psychiatry 17:161-5. 2005
    ....
  17. ncbi request reprint Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder
    Shamsah B Sonawalla
    Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, 15 Parkman Street, Boston, Massachusetts 02114, USA
    Psychosomatics 43:310-6. 2002
    ..05). Elevated serum cholesterol levels appear to be associated with poorer response to fluoxetine treatment. Further studies are needed to confirm our findings...
  18. ncbi request reprint Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder
    George I Papakostas
    Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, Mass 02114, USA
    J Clin Psychiatry 64:1357-61. 2003
    ..The purpose of this study was to test whether the presence of comorbid Axis I and Axis II disorders predicts clinical response to an open trial of nor-triptyline among patients with treatment-resistant depression...
  19. ncbi request reprint Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy
    Andrew A Nierenberg
    Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA
    J Clin Psychiatry 64:13-7. 2003
    ..In addition, psychotherapy, alone or combined with medication, has been shown to be effective in preventing further episodes of depression...
  20. ncbi request reprint The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists
    Christina M Dording
    Depression Clinical and Research Group, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Ann Clin Psychiatry 14:143-7. 2002
    ..In our opinion, this practice may reflect the relative lack of research studies on the role of adjunctive treatments in the management of SSRI-induced side effects and/or the tendency to favor monotherapy over polypharmacy...
  21. ncbi request reprint Body dysmorphic disorder in outpatients with major depression
    Andrew A Nierenberg
    Depression Research Program, Clinical Psychopharmacology Unit, Massachusetts General Hospital and The Consolidated Department of Psychiatry, Harvard Medical School, Boston, MA 02114, USA
    J Affect Disord 69:141-8. 2002
    ..The purpose of this study was to evaluate the rate of BDD in a cohort of consecutive outpatients with typical and atypical major depressive disorder...
  22. ncbi request reprint A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder
    George I Papakostas
    Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    J Clin Psychopharmacol 26:56-60. 2006
    ....
  23. doi request reprint Depression and suicidal ideation in college students
    Amy Farabaugh
    Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA 02114, USA
    Psychopathology 45:228-34. 2012
    ..Suicide is one of the leading causes of death in college students and is often associated with depression. The aim of this study was to assess the rates of suicidal ideation (SI) on college campuses and to identify its correlates...
  24. ncbi request reprint Adjunctive atomoxetine for residual fatigue in major depressive disorder
    George I Papakostas
    Department of Psychiatry, Depression Clinical and Research Program, Massachusetts General Hospital, 15 Parkman Street, WAC 812, Boston, MA 02114, United States
    J Psychiatr Res 40:370-3. 2006
    ..To assess the effectiveness and safety of atomoxetine as an adjunctive medication for residual fatigue in a naturalistic treatment setting...
  25. ncbi request reprint A survey of antidepressant prescribing practices in major depression with comorbid attention-deficit hyperactivity disorder
    George I Papakostas
    J Clin Psychopharmacol 26:216-8. 2006
  26. ncbi request reprint Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trial
    Steven D Hollon
    Department of Psychology, Vanderbilt University, 306 Wilson Hall, Nashville, TN 37203, United States
    J Psychiatr Res 40:59-69. 2006
    ..Recurrent depression predicts risk for subsequent episodes, but it is unclear how it relates to demographic features, course of illness, and clinical presentation...